Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

AIM Stock Latest News

The FlyAIM ImmunoTech announces official print of data analysis for EAP study of PDAC

5d ago

AIM

PremiumPress Releases

AIM ImmunoTech Announces Print Publication and Further Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research

5d ago

AIM

PremiumThe Fly

Morning Movers: MSG Entertainment rises following quarterly release

9d ago

AIM

HRB

PremiumPress Releases

AIM ImmunoTech Reports Second Quarter 2024 Financial Results and Provides Corporate Update

9d ago

AIM

PremiumThe Fly

AIM ImmunoTech reports Q2 EPS (3c), consensus (12c)

9d ago

AIM

PremiumPress ReleasesAIM ImmunoTech to Discuss Second Quarter 2024 Financial Results on August 16, 2024, and Host Conference Call and Webcast

12d ago

AIM

AIM ImmunoTech Announces Release of the Next CEO Corner Segment

Premium

Press Releases

AIM ImmunoTech Announces Release of the Next CEO Corner Segment

27d ago

AIM

AIM Announces New Positive Data on Ampligen’s Anti-Tumor Potential When Used as Part of a Combination Therapy

Premium

Press Releases

AIM Announces New Positive Data on Ampligen’s Anti-Tumor Potential When Used as Part of a Combination Therapy

1M ago

AIM

PremiumThe Fly

AIM ImmunoTech announces data on Ampligen’s anti-tumor potential

1M ago

AIM

PremiumThe Fly

AIM ImmunoTech files to sell 11.28M shares of common stock for holders

1M ago

AIM

PremiumPress Releases

AIM ImmunoTech Announces Release of the Next CEO Corner Segment

2M ago

AIM

PremiumPress Releases

AIM ImmunoTech to Participate in the Virtual Investor Pitch Conference

3M ago

AIM

PremiumPress ReleasesAIM ImmunoTech to Participate in the Virtual Investor Lunch Break Series

3M ago

AIM

AIM ImmunoTech to sell 5.6M shares at 36.3c in registered direct offering

Premium

The Fly

AIM ImmunoTech to sell 5.6M shares at 36.3c in registered direct offering

3M ago

AIM

AIM ImmunoTech Announces Pricing of $2.0 Million Registered Direct Offering

Premium

Press Releases

AIM ImmunoTech Announces Pricing of $2.0 Million Registered Direct Offering

3M ago

AIM

PremiumPress Releases

AIM ImmunoTech to Participate in Two Upcoming Investor Conferences

3M ago

AIM

PremiumPress Releases

AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update

3M ago

AIM

PremiumThe Fly

AIM ImmunoTech reports Q1 EPS (12c) vs (8c) last year

3M ago

AIM

PremiumThe Fly

Biotech Alert: Searches spiking for these stocks today

4M ago

AIM

CVM

PremiumThe FlyBiotech Alert: Searches spiking for these stocks today

4M ago

AIM

BCRX

AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast

Premium

Press Releases

AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast

4M ago

AIM

AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen®

Premium

Press Releases

AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen®

4M ago

AIM

AIM Stock Latest News

Trending

Indices

Stocks

ETFs